Tark Kwan-Chul, Hong Jong-Won, Kim Young-Soo, Hahn Seung-Boem, Lee Won-Jai, Lew Dae-Hyun
Department of Plastic and Reconstructive Surgery, Institute for Human Tissue restoration, Yonsei University College of Medicine, Seoul, Korea.
Ann Plast Surg. 2010 Dec;65(6):565-72. doi: 10.1097/SAP.0b013e3181d9aae2.
In the present study, we used the diabetic mouse as a model of delayed wound healing to investigate the effects of human cord blood mesenchymal stem cells (CB-MSC) on wound healing.
A delayed wound healing model was used by db/db mice. Study models were divided by an injection of human CB-MSC with phosphate buffered solution (PBS) by a different method. One was a locally topical injection, the other was a systemic injection via the end tail vein. Both models were treated with 2.0 × 10(6) CB-MSC after an 8-mm full thickness defect was made by a skin punch biopsy on the back. We evaluated the wound size, transforming growth factor (TGF)-β, and vascular endothelial growth factor histologic evaluation, and vessel counts. Engraft of CB-MSC was detected by an antihuman antibody.
Wound healing was accelerated in the experimental group in the topical injection model with statistical significance on the 6th, 9th, and 12th day (P < 0.05). In the systemic injection model, wound healing was completed from the 9th day, but there was no statistical significance. TGF-β increased in the first week and decreased in the third week in the experimental groups of both models. But there were opposite results in the control groups of both models. The statistical differences were found in first and third week in topical injection and in the third week in systemic injection (P < 0.05). Vascular endothelial growth factor increased in all groups and in all models as the wound healing. But statistical significance did not show between all experimental and control groups. Anti-human antibody immunochemical staining was positive in the wound.
We concluded that CB-MSC had a positive effect on wound healing. Statistically significant results were noted in the topical injection model. We also reported good effects on the systemic injection model, although we did not find any statistical significance. CB-MSC may influence wound healing by TGF-β.
在本研究中,我们将糖尿病小鼠作为伤口愈合延迟的模型,以研究人脐带血间充质干细胞(CB-MSC)对伤口愈合的影响。
使用db/db小鼠建立伤口愈合延迟模型。通过不同方法将人CB-MSC与磷酸盐缓冲溶液(PBS)注射入研究模型中进行分组。一种是局部局部注射,另一种是经尾静脉全身注射。在背部通过皮肤打孔活检造成8毫米全层缺损后,两个模型均用2.0×10⁶个CB-MSC进行治疗。我们评估了伤口大小、转化生长因子(TGF)-β、血管内皮生长因子组织学评估和血管计数。通过抗人抗体检测CB-MSC的植入情况。
在局部注射模型的实验组中,伤口愈合在第6、9和12天加速,具有统计学意义(P<0.05)。在全身注射模型中,伤口从第9天开始愈合,但无统计学意义。两个模型的实验组中,TGF-β在第一周升高,在第三周降低。但两个模型的对照组结果相反。在局部注射的第一周和第三周以及全身注射的第三周发现有统计学差异(P<0.05)。随着伤口愈合,所有组和所有模型中的血管内皮生长因子均升高。但所有实验组和对照组之间未显示出统计学意义。伤口处抗人抗体免疫化学染色呈阳性。
我们得出结论,CB-MSC对伤口愈合有积极作用。在局部注射模型中观察到具有统计学意义的结果。尽管未发现统计学意义,但我们也报告了全身注射模型的良好效果。CB-MSC可能通过TGF-β影响伤口愈合。